DEC 10

Regent Pacific Group Spearheads Deep Longevity’s U.S. Expansion With Key Leadership Appointments Ahead of 2026 Launch


DEC 01

Announces Deep Longevity’s Strategic U.S. Market Entry in Q1 2026


JUL 22

Update on NDA Status for Fortacin/Senstend in China and Positive Progress at Deep Longevity